All-In with Chamath, Jason, Sacks & Friedberg cover image

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

00:00

Who Should Use GLP-1s and Prophylactic Considerations

Dave discusses starting with sickest patients, potential low-dose use in older adults, and safety progression to broader use.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app